Global Hip Osteoarthritis Pain Medicine Market Insights and Forecast to 2026
Table of Contents1 Study Coverage
1.1 Hip Osteoarthritis Pain Medicine Product Introduction
1.2 Market Segments
1.3 Key Hip Osteoarthritis Pain Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.4.4 External
1.5 Market by Application
1.5.1 Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Application
1.5.2 Medical Care
1.5.3 Personal Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hip Osteoarthritis Pain Medicine Market Size, Estimates and Forecasts
2.1.1 Global Hip Osteoarthritis Pain Medicine Revenue 2015-2026
2.1.2 Global Hip Osteoarthritis Pain Medicine Sales 2015-2026
2.2 Global Hip Osteoarthritis Pain Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hip Osteoarthritis Pain Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hip Osteoarthritis Pain Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hip Osteoarthritis Pain Medicine Competitor Landscape by Players
3.1 Hip Osteoarthritis Pain Medicine Sales by Manufacturers
3.1.1 Hip Osteoarthritis Pain Medicine Sales by Manufacturers (2015-2020)
3.1.2 Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Hip Osteoarthritis Pain Medicine Revenue by Manufacturers
3.2.1 Hip Osteoarthritis Pain Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hip Osteoarthritis Pain Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hip Osteoarthritis Pain Medicine Revenue in 2019
3.2.5 Global Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hip Osteoarthritis Pain Medicine Price by Manufacturers
3.4 Hip Osteoarthritis Pain Medicine Manufacturing Base Distribution, Product Types
3.4.1 Hip Osteoarthritis Pain Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hip Osteoarthritis Pain Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Hip Osteoarthritis Pain Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hip Osteoarthritis Pain Medicine Market Size by Type (2015-2020)
4.1.1 Global Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020)
4.1.2 Global Hip Osteoarthritis Pain Medicine Revenue by Type (2015-2020)
4.1.3 Hip Osteoarthritis Pain Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hip Osteoarthritis Pain Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Hip Osteoarthritis Pain Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hip Osteoarthritis Pain Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hip Osteoarthritis Pain Medicine Market Size by Application (2015-2020)
5.1.1 Global Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020)
5.1.2 Global Hip Osteoarthritis Pain Medicine Revenue by Application (2015-2020)
5.1.3 Hip Osteoarthritis Pain Medicine Price by Application (2015-2020)
5.2 Hip Osteoarthritis Pain Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Hip Osteoarthritis Pain Medicine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hip Osteoarthritis Pain Medicine by Country
6.1.1 North America Hip Osteoarthritis Pain Medicine Sales by Country
6.1.2 North America Hip Osteoarthritis Pain Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
6.3 North America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application
7 Europe
7.1 Europe Hip Osteoarthritis Pain Medicine by Country
7.1.1 Europe Hip Osteoarthritis Pain Medicine Sales by Country
7.1.2 Europe Hip Osteoarthritis Pain Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
7.3 Europe Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hip Osteoarthritis Pain Medicine by Region
8.1.1 Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region
8.1.2 Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
8.3 Asia Pacific Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hip Osteoarthritis Pain Medicine by Country
9.1.1 Latin America Hip Osteoarthritis Pain Medicine Sales by Country
9.1.2 Latin America Hip Osteoarthritis Pain Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
9.3 Central & South America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hip Osteoarthritis Pain Medicine by Country
10.1.1 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Country
10.1.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Hip Osteoarthritis Pain Medicine Products Offered
11.1.5 Pfizer Related Developments
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Corporation Information
11.2.2 Johnson and Johnson Description and Business Overview
11.2.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson and Johnson Hip Osteoarthritis Pain Medicine Products Offered
11.2.5 Johnson and Johnson Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Hip Osteoarthritis Pain Medicine Products Offered
11.4.5 Bayer Related Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Description and Business Overview
11.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly Hip Osteoarthritis Pain Medicine Products Offered
11.5.5 Eli Lilly Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Hip Osteoarthritis Pain Medicine Products Offered
11.6.5 Novartis Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Hip Osteoarthritis Pain Medicine Products Offered
11.7.5 Sanofi Related Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Corporation Information
11.8.2 Horizon Pharma Description and Business Overview
11.8.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Horizon Pharma Hip Osteoarthritis Pain Medicine Products Offered
11.8.5 Horizon Pharma Related Developments
11.9 Abbott
11.9.1 Abbott Corporation Information
11.9.2 Abbott Description and Business Overview
11.9.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Abbott Hip Osteoarthritis Pain Medicine Products Offered
11.9.5 Abbott Related Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Description and Business Overview
11.10.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mylan Hip Osteoarthritis Pain Medicine Products Offered
11.10.5 Mylan Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Hip Osteoarthritis Pain Medicine Products Offered
11.1.5 Pfizer Related Developments
11.12 TEVA
11.12.1 TEVA Corporation Information
11.12.2 TEVA Description and Business Overview
11.12.3 TEVA Sales, Revenue and Gross Margin (2015-2020)
11.12.4 TEVA Products Offered
11.12.5 TEVA Related Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Corporation Information
11.13.2 Almatica Pharma Description and Business Overview
11.13.3 Almatica Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Almatica Pharma Products Offered
11.13.5 Almatica Pharma Related Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Corporation Information
11.14.2 Astellas Pharma Description and Business Overview
11.14.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Astellas Pharma Products Offered
11.14.5 Astellas Pharma Related Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Corporation Information
11.15.2 Tide Pharmaceutical Description and Business Overview
11.15.3 Tide Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Tide Pharmaceutical Products Offered
11.15.5 Tide Pharmaceutical Related Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Corporation Information
11.16.2 Iroko Pharmaceuticals Description and Business Overview
11.16.3 Iroko Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Iroko Pharmaceuticals Products Offered
11.16.5 Iroko Pharmaceuticals Related Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Corporation Information
11.17.2 Hengrui Pharmaceutical Description and Business Overview
11.17.3 Hengrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Hengrui Pharmaceutical Products Offered
11.17.5 Hengrui Pharmaceutical Related Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Corporation Information
11.18.2 Abiogen Pharma Description and Business Overview
11.18.3 Abiogen Pharma Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Abiogen Pharma Products Offered
11.18.5 Abiogen Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hip Osteoarthritis Pain Medicine Market Estimates and Projections by Region
12.1.1 Global Hip Osteoarthritis Pain Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
12.2.2 North America: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hip Osteoarthritis Pain Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hip Osteoarthritis Pain Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hip Osteoarthritis Pain Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hip Osteoarthritis Pain Medicine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hip Osteoarthritis Pain Medicine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hip Osteoarthritis Pain Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Hip Osteoarthritis Pain Medicine Market Segments
Table 2. Ranking of Global Top Hip Osteoarthritis Pain Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Major Manufacturers of External
Table 7. Global Hip Osteoarthritis Pain Medicine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Hip Osteoarthritis Pain Medicine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Hip Osteoarthritis Pain Medicine Sales by Regions 2015-2020 (K Units)
Table 10. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Regions (2015-2020)
Table 11. Global Hip Osteoarthritis Pain Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Hip Osteoarthritis Pain Medicine Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Hip Osteoarthritis Pain Medicine Sales Share by Manufacturers (2015-2020)
Table 14. Global Hip Osteoarthritis Pain Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Hip Osteoarthritis Pain Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hip Osteoarthritis Pain Medicine as of 2019)
Table 16. Hip Osteoarthritis Pain Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Hip Osteoarthritis Pain Medicine Price (2015-2020) (USD/Unit)
Table 19. Hip Osteoarthritis Pain Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Hip Osteoarthritis Pain Medicine Product Type
Table 21. Date of International Manufacturers Enter into Hip Osteoarthritis Pain Medicine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020) (K Units)
Table 24. Global Hip Osteoarthritis Pain Medicine Sales Share by Type (2015-2020)
Table 25. Global Hip Osteoarthritis Pain Medicine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Hip Osteoarthritis Pain Medicine Revenue Share by Type (2015-2020)
Table 27. Hip Osteoarthritis Pain Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020) (K Units)
Table 29. Global Hip Osteoarthritis Pain Medicine Sales Share by Application (2015-2020)
Table 30. North America Hip Osteoarthritis Pain Medicine Sales by Country (2015-2020) (K Units)
Table 31. North America Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2015-2020)
Table 32. North America Hip Osteoarthritis Pain Medicine Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2015-2020)
Table 34. North America Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020) (K Units)
Table 35. North America Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2015-2020)
Table 36. North America Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020) (K Units)
Table 37. North America Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2015-2020)
Table 38. Europe Hip Osteoarthritis Pain Medicine Sales by Country (2015-2020) (K Units)
Table 39. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2015-2020)
Table 40. Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2015-2020)
Table 42. Europe Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020) (K Units)
Table 43. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2015-2020)
Table 44. Europe Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020) (K Units)
Table 45. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2015-2020)
Table 54. Latin America Hip Osteoarthritis Pain Medicine Sales by Country (2015-2020) (K Units)
Table 55. Latin America Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Hip Osteoarthritis Pain Medicine Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2015-2020)
Table 58. Latin America Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020) (K Units)
Table 59. Latin America Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2015-2020)
Table 60. Latin America Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020) (K Units)
Table 61. Latin America Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Johnson and Johnson Corporation Information
Table 76. Johnson and Johnson Description and Major Businesses
Table 77. Johnson and Johnson Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Johnson and Johnson Product
Table 79. Johnson and Johnson Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Major Businesses
Table 82. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Major Businesses
Table 92. Eli Lilly Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly Product
Table 94. Eli Lilly Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Horizon Pharma Corporation Information
Table 106. Horizon Pharma Description and Major Businesses
Table 107. Horizon Pharma Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Horizon Pharma Product
Table 109. Horizon Pharma Recent Development
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Major Businesses
Table 112. Abbott Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Abbott Product
Table 114. Abbott Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Major Businesses
Table 117. Mylan Hip Osteoarthritis Pain Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Mylan Product
Table 119. Mylan Recent Development
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Major Businesses
Table 122. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Daiichi Sankyo Product
Table 124. Daiichi Sankyo Recent Development
Table 125. TEVA Corporation Information
Table 126. TEVA Description and Major Businesses
Table 127. TEVA Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. TEVA Product
Table 129. TEVA Recent Development
Table 130. Almatica Pharma Corporation Information
Table 131. Almatica Pharma Description and Major Businesses
Table 132. Almatica Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Almatica Pharma Product
Table 134. Almatica Pharma Recent Development
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Major Businesses
Table 137. Astellas Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Astellas Pharma Product
Table 139. Astellas Pharma Recent Development
Table 140. Tide Pharmaceutical Corporation Information
Table 141. Tide Pharmaceutical Description and Major Businesses
Table 142. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Tide Pharmaceutical Product
Table 144. Tide Pharmaceutical Recent Development
Table 145. Iroko Pharmaceuticals Corporation Information
Table 146. Iroko Pharmaceuticals Description and Major Businesses
Table 147. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Iroko Pharmaceuticals Product
Table 149. Iroko Pharmaceuticals Recent Development
Table 150. Hengrui Pharmaceutical Corporation Information
Table 151. Hengrui Pharmaceutical Description and Major Businesses
Table 152. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Hengrui Pharmaceutical Product
Table 154. Hengrui Pharmaceutical Recent Development
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Major Businesses
Table 157. Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Abiogen Pharma Product
Table 159. Abiogen Pharma Recent Development
Table 160. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Regions (2021-2026) (K Units)
Table 161. Global Hip Osteoarthritis Pain Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 162. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 163. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 164. North America: Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 165. North America: Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Europe: Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 167. Europe: Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Asia Pacific: Hip Osteoarthritis Pain Medicine Sales Forecast by Region (2021-2026) (K Units)
Table 169. Asia Pacific: Hip Osteoarthritis Pain Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 170. Latin America: Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 171. Latin America: Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Middle East and Africa: Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2021-2026) (K Units)
Table 173. Middle East and Africa: Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 175. Key Challenges
Table 176. Market Risks
Table 177. Main Points Interviewed from Key Hip Osteoarthritis Pain Medicine Players
Table 178. Hip Osteoarthritis Pain Medicine Customers List
Table 179. Hip Osteoarthritis Pain Medicine Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of FiguresFigure 1. Hip Osteoarthritis Pain Medicine Product Picture
Figure 2. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application in 2020 & 2026
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Hip Osteoarthritis Pain Medicine Report Years Considered
Figure 10. Global Hip Osteoarthritis Pain Medicine Market Size 2015-2026 (US$ Million)
Figure 11. Global Hip Osteoarthritis Pain Medicine Sales 2015-2026 (K Units)
Figure 12. Global Hip Osteoarthritis Pain Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2015-2020)
Figure 14. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region in 2019
Figure 15. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2015-2020)
Figure 16. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Region in 2019
Figure 17. Global Hip Osteoarthritis Pain Medicine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Hip Osteoarthritis Pain Medicine Revenue in 2019
Figure 19. Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2015-2020)
Figure 21. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type in 2019
Figure 22. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2015-2020)
Figure 23. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type in 2019
Figure 24. Global Hip Osteoarthritis Pain Medicine Market Share by Price Range (2015-2020)
Figure 25. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2015-2020)
Figure 26. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application in 2019
Figure 27. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application (2015-2020)
Figure 28. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application in 2019
Figure 29. North America Hip Osteoarthritis Pain Medicine Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Hip Osteoarthritis Pain Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Hip Osteoarthritis Pain Medicine Sales Market Share by Country in 2019
Figure 32. North America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country in 2019
Figure 33. U.S. Hip Osteoarthritis Pain Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Hip Osteoarthritis Pain Medicine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Hip Osteoarthritis Pain Medici